Vaccination programs for children aged up to 18 years in Europe,2020

Abstract

Although all European countries have vaccination policies for children, there are no comprehensive studies of pediatric vaccination programs in Europe. We studied vaccination programs for children in Europe. Vaccinations against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b, hepatitis B, measles, mumps, rubella, and influenza existed in 42 countries, against human papilloma virus in 41 countries, and against pneumococcus in 40 countries. In addition, the following vaccinations existed: against tuberculosis (35 countries), hepatitis A (33), meningococcus A, C, W, Y (30), rotavirus and varicella (28 countries each), meningococcus B (24), tick-born encephalitis (22), and meningococcus C (16). Mandatory vaccinations are implemented in 21 countries, mainly against diphtheria, tetanus, pertussis, poliomyelitis, H. influenzae type b, hepatitis B, measles, mumps, rubella, tuberculosis, and pneumococcus. There are significant differences among pediatric vaccination programs in Europe regarding number, schedules, indications, and regulatory frame (recommended or mandatory vaccinations). A consensus-based vaccination program for all children is needed.

Keywords

vaccinations immunizations programs children pediatric Europe

Get full access to this article

View all access options for this article.

References

Allerberger

(2017) Eliminating measles and rubella in Europe. Clinical Microbiology and Infection 23: 502–503. DOI: 10.1016/j.cmi.2017.04.008.

Ardura-Garcia

Kreis

Rakic

, et al. (2021) Rotavirus disease and health care utilisation among children under 5 years of age in highly developed countries: a systematic review and meta-analysis. Vaccine 39: 2917–2928. DOI: 10.1016/j.vaccine.2021.04.039.

Bitzegeio

Bukowski

Hausner

, et al. (2020) Two measles clusters in connection with short inner-European air travels indicating impediments to effective measles control: a cluster analysis. Travel Medicine and Infectious Disease 33: 101542. DOI: 10.1016/j.tmaid.2019.101542.

Cassimos

Effraimidou

Medic

, et al. (2020) Vaccination programs for adults in Europe, 2019. Vaccines 8: 34. DOI: 10.3390/vaccines8010034.

Centers for Disease Control and Prevention (2015) Global health. Available from: https://www.cdc.gov/globalhealth/immunization/ (accessed 18 December 2020).

Cohen

Gaudelus

Leboucher

et al. (2019) Impact of mandatory vaccination extension on infant vaccine coverages: promising preliminary results. Médecine et Maladies Infectieuses 49: 34–37. DOI: 10.1016/j.medmal.2018.10.004.

Decree-law (2017) n. 73, containing“urgent provisions concerning vaccination prevention” gazzetta ufficiale; general series, n.130. Available from: http://www.gazzettaufficiale.it/eli/id/2017/08/05/17A05515/sg (accessed 18 December 2020).

Doherty

Buchy

Standaert

, et al. (2016) Vaccine impact: benefits for human health. Vaccine 34: 6707–6714. DOI: 10.1016/j.vaccine.2016.10.025.

Dretler

Rouphael

Stephens

(2018) Progress toward the global control of neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development. Human Vaccines & Immunotherapeutics 14: 1146–1160. DOI: 10.1080/21645515.2018.1451810.

10.

European Centre for Disease Prevention and Control (2015) Current practices in immunisation policymaking in European countries. 2017. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/Current-practices-on-immunisation-policymaking-processes-Mar-2015.pdf (accessed 18 December 2020).

11.

European Centre for Disease Prevention and Control (2020a) Monthly measles and rubella monitoring report. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/measels-rubella-monthly-report-january-2020.pdf (accessed 22 August 2021).

12.

European Centre for Disease Prevention and Control (2020b) Vaccine scheduler. Available from https://vaccine-schedule.ecdc.europa.eu/ (accessed 18 December 2020).

13.

European Commission (2018) Press release: vaccination: commission calls for stronger EU cooperation against preventable diseases. Available from: http://europa.eu/rapid/press-release_IP-18-3457_en.htm (accessed 18 December 2020).

14.

European Commission (2020) Live, work, travel in the EU - public health – vaccination. Available from: https://ec.europa.eu/health/vaccination/overview_en (accessed 18 December 2020).

15.

Eythorsson

Ásgeirsdóttir

Erlendsdóttir

, et al. (2021) The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland-A population-based time series analysis. PloS One 16: e0249497. DOI: 10.1371/journal.pone.0249497.

16.

Gossner

Severi

Danielsson

, et al. (2015) Changing hepatitis A epidemiology in the European union: new challenges and opportunities. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20(16). pii=21101, Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=21101

17.

Gualano

Olivero

Voglino

, et al. (2019) Knowledge, attitudes and beliefs towards compulsory vaccination: a systematic review. Human Vaccines & Immunotherapeutics 15(4): 918–931. DOI: 10.1080/21645515.2018.1564437.

18.

Holt

(2018) 41 000 measles cases in Europe since the beginning of 2018. Lancet 392: 724. DOI: 10.1016/S0140-6736(18)32031-2.

(2020) Combating vaccine hesitancy and other 21st century social determinants in the global fight against measles. Current Opinion in Virology 41: 1–7. Available from: https://pubmed.ncbi.nlm.nih.gov/32113136/

20.

Kirolos

Waugh

Templeton

, et al. (2018) Imported case of measles in a university setting leading to an outbreak of measles in Edinburgh, Scotland from September to December 2016. Epidemiology and Infection 146: 741–746. DOI: 10.1017/S0950268818000602. Epub 2018 Mar 22.

21.

Lang

Loving

McCarthy

, et al. (2020) Two centuries of immunisation in the UK (part II). Archives of Disease in Childhood 105: 216–222. Available from: https://pubmed.ncbi.nlm.nih.gov/31302603/

22.

Lopalco

de Carvalho

Kreidl

, et al. (2009) Childhood vaccination schedules in Europe vary widely. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 52: 1095–1098. DOI: 10.1007/s00103-009-0960-z.

, et al. (2019a) Vaccination of healthcare personnel in Europe: update to current policies. Vaccine 37: 7576–7584. DOI: 10.1016/j.vaccine.2019.09.061.

(2019b) Mandatory vaccinations for children in Italy: the need for a stable frame. Vaccine 37: 4419–4420. https://pubmed.ncbi.nlm.nih.gov/31280946/

25.

Ministry of Health (2018) Subject: vaccination coverage at 24 months, 36 months and 5-6 years of age (per 100 habitants) by region and by antigen. Available from: http://www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?lingua=italiano&menu=notizie&p=dalministero&id=3633 (accessed 18 December 2020).

26.

Nguyen-Huu

N-H

Thilly

Derrough

, et al. (2020) Human papillomavirus vaccination coverage, policies, and practical implementation across Europe. Vaccine 38: 1315–1331. DOI: 10.1016/j.vaccine.2019.11.081.

27.

Nichol

(2011) Cost-effectiveness and socio-economic aspects of childhood influenza vaccination. Vaccine 29: 7554–7558. Available from: https://pubmed.ncbi.nlm.nih.gov/21820477/

28.

Patel

Brotherton

Pillsbury

, et al. (2018) The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Eurosurveillance 23: 41. DOI: 10.2807/1560-7917.ES.2018.23.41.1700737.

29.

Pavli

Maltezou

(2017) Health problems of newly arrived migrants and refugees in Europe. Journal of Travel Medicine 24: 4. DOI: 10.1093/jtm/tax016.

, et al. (2018) A report on the status of vaccination in Europe. Vaccine 36: 4979–4992. DOI: 10.1016/j.vaccine.2018.06.044 .

, et al. (2019) The necessity of education and hepatitis B vaccination for young people: a study of high risk behaviour for blood borne viruses in the United Kingdom. Journal of Child Health Care 23: 437–445. Available from: https://journals.sagepub.com/doi/10.1177/1367493519831499

32.

Smith

Amlôt

Weinman

, et al. (2017) A systematic review of factors affecting vaccine uptake in young children. Vaccine 35: 6059–6069. DOI: 10.1016/j.vaccine.2017.09.046.

, et al. (2019) Seroprotection rates of vaccine-preventable diseases among newly arrived eritrean asylum seekers in Switzerland: a cross-sectional study. Journal of Travel Medicine 26. taz035. DOI: 10.1093/jtm/taz035.

(2009) The need for new vaccines. Vaccine 27(suppl. 6): G3–G8. DOI: 10.1016/j.vaccine.2009.10.014 .

35.

University of Oxford (2020) The vaccine knowledge project. Vaccination schedules in other countries. Available from: http://vk.ovg.ox.ac.uk/vaccination-schedules-other-countries (accessed 18 December 2020).

36.

World Health Organization (2014) European vaccine action plan 2015-2020. Available from: http://www.euro.who.int/__data/assets/pdf_file/0007/255679/WHO_EVAP_UK_v30_WEBx.pdf (accessed 18 December 2020).

37.

World Health Organization (2020) Vaccine-preventable diseases: monitoring system. 2020 global summary. Available from: http://apps.who.int/immunization_monitoring/globalsummary/countries?commit=OK (accessed 18 December 2020).

38.

World Health Organization (2021) Immunization and vaccine-preventable communicable diseases. Available from: https://www.who.int/data/gho/data/themes/immunization (accessed 22 August 2021).

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.15 MB